| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |